BioSpace News Archive

Envoy Medical® Corporation today announced that a lawsuit filed against the Company by Gene Berghoff has been voluntarily dismissed with prejudice.

Medical practice is characterized as the science and the specialty of mending as per logical determination of the infection.

According to the report, the global medical laser systems market was valued at ~US$ 2 Bn in 2019 and is projected to expand at a higher CAGR during the forecast period.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors.

Biophytis SA announces the recommendation by the Data Monitoring Committee to continue the Phase 2-3 COVA study without any modification of the protocol, after the interim efficacy data were found in the promising zone in the Interim Analysis 2 based on 155 COVID-19 patients hospitalized with respiratory failure.

Guardant Health, Inc., along with leading academic institutions and pharmaceutical companies, share data highlighting molecular targets of importance, treatment resistance patterns, and advantages of using the Guardant360® liquid biopsy test to help improve the management of advanced solid cancers at the European Society for Medical Oncology 2021 virtual congress on September 16-21.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that John Bencich, Chief Executive Officer, will participate in two upcoming investor conferences.

Theravance Biopharma, Inc. announced strategic actions to focus on leveraging its expertise in developing and commercializing respiratory therapeutics in order to maximize shareholder value.

iPharma Labs, Inc., a privately-held contract development research organization specializing in inhalation pharmaceutical development services, announced the implementation of GMP services for release testing for inhalation clinical trials.

Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a specialty pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced that it will present virtually at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, Monday, September 20, 2021, 2:05 p.m. ET.